Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
In this episode, Javier Tordable, founder and CEO of Pauling.ai and former Google technologist, explains how modern large language models have evolved into autonomous AI agents capable of executing multi‑step scientific workflows, from literature synthesis to hypothesis generation and computational chemistry simulations. He details how these agents accelerate early‑stage drug discovery by identifying targets, designing molecules, and optimizing clinical trials, while emphasizing the continued need for human creativity and experimental validation. The conversation also addresses the risks of hallucinations and data quality, advocating for hybrid AI‑physics approaches to ensure trustworthy results. Listeners gain a clear view of how LLM‑driven automation can compress R&D timelines and reshape pharma research.
Researchers are investigating L‑fucose, a rare monosaccharide, as a novel adjunct in cancer therapy. Pre‑clinical models show that supplementing L‑fucose can modulate tumor glycosylation, enhancing immune recognition and reducing metastatic spread. Early phase trials report improved response rates when L‑fucose...
New research published in Journal of Evolutionary Psychology shows that hormonal contraceptives significantly alter women's emotional responses, increasing jealousy toward perceived rivals and amplifying competitive drives. The study, which surveyed over 1,200 women across multiple countries, found that synthetic estrogen...
The 2026 catalyst calendar for neuroscience highlights a surge of late‑stage readouts in psychedelics, epilepsy, and genetically driven neurodegeneration. The analysis, based on a 25‑slide deck, points to upcoming Phase III trials, regulatory decisions, and proof‑of‑concept data that could unlock new...
An international research team, led by scientists from ANU, unveiled a silicon‑nanopore technique that watches transfer‑RNA (tRNA) molecules in real time. By squeezing over three million tRNA samples through tiny membrane holes, the method captures how single‑letter mutations reshape the...
A recent study published by bioengineer.org identifies a network of mitochondrial regulators that modulate α‑synuclein aggregation, a hallmark of Parkinson’s disease and related neurodegenerative disorders. Using CRISPR‑based screens and proteomic profiling, researchers pinpointed five key proteins that restore mitochondrial dynamics...
CMS announced the selection of Eli Lilly’s GLP‑1 diabetes drug Trulicity and Gilead’s HIV therapy Biktarvy for the third round of Medicare drug price negotiations under the Inflation Reduction Act. The program, now in its third cycle, expands the list...
A six‑year, multi‑center cohort study has identified a strong link between maternal vitamin D deficiency and neonatal hypocalcemia. Infants born to mothers with serum vitamin D below 20 ng/mL were significantly more likely to present low calcium levels within the first...
Recent studies reveal that alcohol consumption significantly undermines adherence to HIV prevention regimens, particularly pre‑exposure prophylaxis (PrEP). Heavy drinkers miss up to 30% more doses and are less likely to attend follow‑up appointments. The relationship persists across diverse demographics, driven...
Scientists at Oregon State University have engineered an iron‑based metal‑organic framework that simultaneously generates hydroxyl radicals and singlet oxygen within cancer cells, exploiting the acidic, hydrogen‑peroxide‑rich tumor microenvironment. This dual‑reactive‑oxygen‑species approach achieved complete tumor regression in mice bearing human breast...
A research team has unveiled a scalable framework that builds contact matrices directly from real‑time mobility data, enabling more granular pandemic modeling. The approach dynamically adjusts interaction patterns as people move, and can be applied to national‑scale populations without prohibitive...
Drug Hunter’s December 2025 patent roundup spotlights four high‑impact filings: Dark Blue Therapeutics’ MLLT1/3 degraders, Insilico Medicine’s KRAS(G12V) inhibitors with demonstrated in‑vivo efficacy, Biohaven’s TRPM2 antagonists for pain, and Rome Therapeutics’ LINE‑1 reverse‑transcriptase prodrugs for oncology. These disclosures reflect rapid...
Researchers at the University of Nebraska–Lincoln have unveiled a hydrogel‑based actuator that mimics biological muscle by embedding microgel units within a microfluidic circulatory network. The system delivers rapid chemical or thermal stimuli, allowing actuation in non‑aqueous environments and achieving faster...
Recent pre‑clinical studies reveal that gut microbiota profoundly influence Parkinson’s disease (PD) pathology in animal models. Germ‑free mice exhibit reduced α‑synuclein aggregation, while colonisation with PD‑patient fecal material accelerates motor deficits and neuroinflammation. Specific bacterial taxa and their metabolites, particularly...
Researchers from Greifswald, Bonn and Buenos Aires have shown that net‑casting spiders actively adjust silk stiffness by altering the microstructure of individual threads. By adding crinkled, “curly” fibers to elastic strands, the spiders create a silk that stretches up to...
The Centers for Medicare & Medicaid Services (CMS) has unveiled a proposal to raise hospital reimbursement rates for drugs that are manufactured in the United States. Under the plan, the outpatient prospective payment system would grant higher payments for domestically...
Immunis announced interim Phase 2 results for its IMM01‑STEM secretome therapy in 47 obese seniors with muscle loss and metabolic dysfunction. The double‑blind, placebo‑controlled study showed a 26 % improvement in gait speed, a validated marker of overall health. Preclinical data also...
Researchers led by Du et al. unveiled an integrated platform that concurrently detects structural variants and single‑nucleotide polymorphisms. The system leverages machine‑learning algorithms to boost copy‑number variation detection and uncover pathogenic alleles in Mendelian families lacking diagnoses. By handling large‑scale...
Cardiff Oncology (CRDF) saw its shares tumble more than 30% after it released mixed Phase 2 results for its lead oncology candidate. The trial met several secondary endpoints but failed to achieve its primary efficacy goal, prompting uncertainty about the...
A team at Peking University built a soft robotic fish that can reconfigure between eel‑like (anguilliform) and tuna‑like (carangiform) swimming styles. By adjusting body stiffness, the platform directly measured how wave propagation and stiffness affect thrust, speed, and maneuverability. In...
A new study by Crous, Kanareck, Thomas and colleagues evaluates an educational program that equips mental‑health staff to lead advance‑care‑planning conversations with older adults suffering from mental illness. The curriculum combines workshops, role‑playing, and digital tools to improve knowledge of...
The United States formally withdrew from the World Health Organization on January 22, 2026, citing alleged failures and politicization. The exit threatens to fracture the global regulatory framework that pharmaceutical companies rely on for drug approval and quality standards. It also jeopardizes...
Texas A&M researchers unveiled the patented Black Soldier Fly Billet, a pint‑sized, room‑temperature storage system that keeps newborn larvae viable for weeks or months. The sealed container combines fermented feed, larvae, and a dry food blanket, extending the typical two‑to‑four‑day...
Raj Puri, chief commercial officer of Argonaut Manufacturing, warns that tariffs, soaring U.S. investment and compressed product timelines are forcing CDMOs onto a tight operational rope. A seven‑figure tariff on key equipment illustrates how trade policy can cripple ROI calculations...
Intellia Therapeutics received FDA clearance to resume one of its two pivotal Phase 3 gene‑editing trials targeting hereditary transthyretin amyloidosis (hATTR). The agency had placed a partial clinical hold earlier this year over safety concerns, but after additional data the hold...
The U.S. Food and Drug Administration lifted its clinical hold on Intellia Therapeutics' MAGNITUDE‑2 Phase III trial of the CRISPR‑based therapy nex‑z for hereditary transthyretin amyloidosis with polyneuropathy (ATTRv‑PN). The company announced that patient enrollment will resume, prompting a 10 % rise...
GSK’s adjuvanted recombinant RSV vaccine Arexvy received European Commission approval on Jan. 26, 2026 for all adults 18 years and older, expanding beyond its prior indication for seniors and high‑risk 50‑59‑year‑olds. The EU estimates roughly 158,000 adult RSV‑related hospitalisations each year, underscoring the...
AstraZeneca has terminated its Phase II cardiovascular drug program, pulling the study from the clinical pipeline. The decision coincides with the simultaneous dissolution of a collaboration between biotech Lisata and Chinese partner Qilu, ending a joint development effort. Both moves...
Huahui Health’s libevitug has secured conditional approval from China’s NMPA, marking the nation’s first domestically approved drug for chronic hepatitis D. The antibody blocks the PreS1 domain of HBV and HDV, preventing viral entry into liver cells. Previously, only Gilead’s Hepcludex...
The University of North Carolina at Chapel Hill has unveiled a DNA‑based platform that adds deoxythymidine (dT) overhangs to the 5′ end of the antisense strand of siRNAs. This modification dramatically improves guide‑strand loading into the RNA‑induced silencing complex, delivering...
Baseline Therapeutics, a San Francisco biotech, has launched its GLP‑1 analog BT‑001 to treat alcohol use disorder (AUD). The company has secured FDA alignment and will begin two randomized, placebo‑controlled Phase III trials this year. Baseline also plans to expand BT‑001 into...
A new multimodal AI system can analyze caregiving photographs, extracting contextual cues such as patient posture, environment safety, and medication usage. The model, trained on millions of annotated images, achieves roughly 92% accuracy in identifying risk factors like falls or...
Cognizant’s senior data scientist Abhijit Nayak explains why transformer models that shine on curated oncology NLP benchmarks falter in clinical settings. He highlights that real‑world pathology reports and clinical notes are highly heterogeneous, demanding modular extraction pipelines with robust validation,...
The U.S. Food and Drug Administration has granted Life Biosciences IND clearance to begin a first‑in‑human gene‑therapy trial aimed at reversing cellular aging. The study will test an epigenetic reprogramming platform that delivers modified mRNA encoding Yamanaka factors to rejuvenate...
Boehringer Ingelheim has licensed SIM0709, a bispecific antibody targeting IL‑23p19 and TL1A, from China’s Simcere in a deal valued at up to €1.05 billion. The agreement includes a €42 million upfront payment and milestone‑based payouts. SIM0709 is in pre‑clinical development and aims...
A recent study by Zhang et al. demonstrates that the adipokine Vaspin can attenuate insulin resistance in gestational diabetes by modulating oxidative stress and nitric‑oxide pathways. In vitro and in vivo experiments showed Vaspin lowers reactive oxygen species and enhances endothelial...
A multinational research team applied metagenomics, metatranscriptomics and metabolomics to alpine soils and discovered a dramatic, short‑lived bloom of microbes during spring snowmelt. The analysis pinpointed fast‑growing bacterial families such as Pseudomonadaceae and Burkholderiaceae that surged by up to 150‑fold...
Roche’s most advanced obesity candidate achieved an average 18.3% weight reduction in a Phase 2 study after nearly a year of treatment. The trial enrolled patients with moderate to severe obesity and demonstrated sustained efficacy without major safety signals. Based on...
Nimbus Therapeutics, founded in 2009, has built a successful small‑molecule drug engine without owning any laboratories, relying on a Design‑Make‑Test‑Analyze (DMTA) learning loop executed through CRO partners. By keeping hypothesis generation, molecular design, data integration and decision‑making in‑house, the company...
Roche announced phase‑2 results for its dual GIP/GLP‑1 obesity drug CT‑388, showing a placebo‑adjusted 22.5% weight loss at the 24 mg dose after 48 weeks. More than half of participants fell below the obesity BMI threshold, and 96% lost at least...
A recent multi‑center study evaluated the incidence of hearing loss among patients receiving chronic myeloid leukemia (CML) tyrosine‑kinase inhibitors (TKIs). The analysis of 1,200 patients over five years found a 7% clinically significant ototoxicity rate, most pronounced with second‑generation TKIs....
Didn’t know $RHHBY was in obesity? They are. Genentech’s CT-388 (dual GLP-1/GIP) showed Ph2 data (n=469) & it might be differentiated (TBD): >48w: −22.5% PBO-adj (efficacy est) / −18.3% treatment-regimen >BMIpreDM to normoglycemia: 73% vs 7.5% >d/c: 5.9% vs 1.3% >No plateau; clear dose-response 💡Mechanistic...
Why is the UK so far behind peer countries in terms of the diseases it screens babies for at birth, diseases for which early treatment makes an enormous difference? @statnews 's @DrewQJoseph explores why. https://t.co/stNqZdcV94
Researchers have identified that the soluble G protein of respiratory syncytial virus (RSV) directly engages Toll‑like receptor 2 (TLR2), facilitating viral dissemination. The interaction triggers TLR2‑dependent signaling that dampens interferon‑mediated antiviral defenses, boosting RSV replication in cultured airway cells. Inhibition...
How crosstalk at the immune synapse shapes T cell and dendritic cell biology https://t.co/DtqWi1PWhU https://t.co/Yw3sO2UgSX
You inherit someone else’s bioinformatics code. No comments. No structure. Variable names like x1, foo, temp2. And now it’s your problem. Let’s talk about that experience—and how to do better. https://t.co/RqCDNPwhMD
Researchers have identified the small‑molecule inhibitor GW4869 as a potent blocker of glioblastoma progression and chemoresistance. In pre‑clinical mouse models, GW4869 reduced tumor volume by roughly 45% and, when paired with temozolomide, extended median survival by 30%. The compound works...
Researchers applied PANDORA‑seq to profile small non‑coding RNAs in mouse and human sperm across the lifespan, uncovering an "aging cliff" marked by abrupt shifts in tRNA‑derived (tsRNA) and rRNA‑derived (rsRNA) small RNAs. In aged sperm heads, rsRNAs lengthened while shorter...
Researchers have created an interferometric nanostrain sensor that measures solid‑liquid interfacial tension of unlabeled protein drops with sub‑0.25 mN m⁻¹ resolution. Using fetal bovine serum, the device shows that γSL declines as protein concentration rises while γSV stays unchanged. Beyond the expected...
Elmira Jalilian and colleagues published a study in Small (June 2026) showing that the tissue source of mesenchymal stem cells (MSCs) and whether they are cultured in two‑dimensional versus three‑dimensional environments dictate the microRNA cargo of extracellular vesicles (EVs) and...
